PlatformQ Health is excited to announce an influx of upcoming June programs including both accredited online healthcare provider activities and patient education sessions produced in collaboration with some of the leading aligned professional organizations, centers of excellence and patient advocacy groups. Despite recent travel and in-person meeting restrictions due to COVID-19, the PlatformQ Health production team has kept scheduled partner programs on timeline by leveraging their proprietary software, virtual event and videobridge technology, allowing the program speakers and attendees to engage in discussion from the safety of their own homes with the ability to measure improvements in patient and provider health outcomes.
Save your Virtual Seat for these Upcoming June Programs
Tuesday June 16th at 12PM EST: Refining Risk-Based Treatment Decisions in the Era of Kidney-Sparing Options for Upper Tract Urothelial Carcinoma
In this upcoming CME session developed in partnership with Large Urology Group Practice Association (LUGPA), Dr. Neal Shore and Dr. Phillip Pierorazio will discuss integrating diagnostic techniques to improve grading and risk stratification of UTUC, review endoscopic diagnosis and management, differentiate kidney-sparing treatment strategies and assess the safety of current and emerging risk-based treatment approaches. The activity is accredited for 1 AMA PRA Category 1 Credit™.
Wednesday June 17th at 12PM EST: Mitigating Risk for Cardiovascular Disease in Narcolepsy
Produced in collaboration with Atlanta School of Sleep Medicine and Technology, the faculty, including top cardiology and sleep experts, and a dietitian, will engage in an interactive discussion about current and emerging evidence to manage people with narcolepsy – cataplexy (type I) using a combination of medications and behavioral interventions to reduce the likelihood of stroke, myocardial infarction, heart failure and cardiac arrest in this vulnerable population. The activity is accredited for 1 AMA PRA Category 1 Credit™
Thursday June 18th at 3PM EST: Optimizing Prophylaxis Strategies of Hemophilia A with or without Inhibitors: For Whom, When, and How Long?
Developed in partnership with leading hemophilia foundations, Hemophilia Federation of America (HFA), National Hemophilia Foundation (NHF) and leading rare disease advocacy group, National Organization for Rare Disorders (NORD), upon completion of this CME session, HCPs will feel more comfortable identifying the numerous clinical factors when determining a therapeutic plan for patients with hemophilia A, evaluating the mechanisms, safety and efficacy of currently available products for bleeding prophylaxis and summarizing best practices. The activity is accredited for 1 AMA PRA Category 1 Credit™.
Tuesday June 23rd at 12PM EST: Metastatic HER2-Positive Disease: Overcoming HER2 Resistance
In collaboration with Susan G Komen Breast Cancer Foundation, this session will feature experts Dr. Ann Partridge and Dr. Adam Brufsky as they evaluate therapeutic options for the HER2 blockade in the first-line setting for HER2-positive MBC, compare and contrast safety and efficacy data in the second-line setting and beyond for HER2-positive MBC, and more in this upcoming CME session! The activity is accredited for 1 AMA PRA Category 1 Credit™.
Tuesday June 23rd at 1PM EST: A Woman’s Role in Her Breast Cancer Care
In this program produced in collaboration with Susan G Komen Breast Cancer Foundation, patients, caregivers, and family members are invited to learn about how breast cancer is diagnosed, why subtypes matter, existing and emerging treatment options, and how to manage side effects. Hear from real patients with breast cancer on their own experience from diagnosis to treatment!
Friday June 26th at 12PM EST: BRAF-Mutated Melanoma: Optimizing Treatment & Addressing Challenges in the Adjuvant and Metastatic Settings
Tune in to learn more from experts and Melanoma Research Foundation (MRF) about evaluating the timing and importance of BRAF testing at diagnosis to facilitate treatment decision making, evaluating safety and efficacy data for immunotherapies and BRAF/MEK therapies for the management of Stage III and IV melanoma and identifying strategies to monitor and evaluate adverse events associated with current and emerging combination approaches. The activity is accredited for 1 AMA PRA Category 1 Credit™.
Tuesday June 30th at 2:30PM EST: Bleeding Management in Patients Receiving Direct Anticoagulants
A Case-Based Approach – Part 1 & 2
Produced and developed in collaboration with American College of Emergency Physicians (ACEP), the expert faculty will discuss the management of patients who receive direct anticoagulant (DOAC) for the management of atrial fibrillation and other thrombotic conditions presenting in the emergency room with major bleeding due to a variety of reasons. This two-part educational activity will demonstrate the application of current guidelines, recommendations, and latest evidence on the use of reversal agents in patients with major hemorrhage receiving DOACs. Each part of this activity is accredited for .5 AMA PRA Category 1 Credit™. More information and registration page coming soon!
Watch Recent June Programs On-Demand Starting Today!
On-Demand CME Session: Refining Patient Selection for Biomarker-Directed Immunotherapy
Produced in collaboration with Society for Immunotherapy of Cancer (SITC), join Dr. Roy Herbst and Dr. Ignacio Wistuba for a CME session that examines the variety of biomarkers associated with immune checkpoint inhibitor therapy. The program speakers will provide guidance on selecting appropriate, evidence-based testing modalities for patients who are potential candidates for immune checkpoint inhibitor therapy and interpret testing results effectively. The activity is accredited for 1 AMA PRA Category 1 Credit™.
On-Demand Patient Education Session: A Closer Look at Hemophilia Management: Improving Outcomes with Personalized Care
This interactive, expert-led HCP-patient-family education activity developed with leading hemophilia foundations, Hemophilia Federation of America (HFA), National Hemophilia Foundation (NHF) and leading rare disease advocacy group, National Organization for Rare Disorders (NORD) includes questions that patients and families have regarding their treatment and overall care, tips for working with the health care team, and helpful strategies that other families have employed to address day-to-day challenges. Learn from real patients and parents of children living with hemophilia.
On Demand CME Session: Dyslipidemia, Diabetes, And Cardiovascular Risk: Clinical Strategies and Evolving Treatments
This CME session produced with Joslin Diabetes Center and American Society of Preventive Cardiology features Dr. Richard Beaser, Dr. Om P. Ganda, and Dr. Deepak Bhatt discussing how to best overcome clinical barriers to the timely and effective therapeutic initiation of the latest antidiabetes and dyslipidemia lipid treatments that have demonstrated cardiovascular benefits. The activity is accredited for 1 AMA PRA Category 1 Credit™.
On Demand LUGPA Crossfire Series Session: Utilizing mpMRI and Genomic Testing for Management of Low and Intermediate Risk Prostate Cancer
This module developed with Large Urology Group Practice Association (LUGPA) provides education on how MRI and GPS TM testing can be complementary for assessing risk of adverse pathology and making the active surveillance decision in low and favorable-intermediate risk patients.
Want more information about one of these activities or our production process? Email us at info@platformq.com